At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 93 enrolled
Drug / intervention
Doxycycline hyclate (Doryx) +1 moredrug
Likely dose
Doxycycline hyclate (Doryx) 150mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Open-label Study to Evaluate the Efficacy and Safety of Doryx Tablets Compared to Doxycycline Hyclate in the Treatment of Acne Vulgaris.
In Brief
A Phase 4 clinical trial evaluating Doxycycline hyclate (Doryx) and Doxycycline hyclate for Acne Vulgaris. Completed, enrolled 93 participants across 4 sites.
Detailed Summary
Randomized, multi-center, open label, active-comparator study to compare the efficacy and tolerability of Doryx Delayed Release Tablets to doxycycline hyclate in patients with moderate to severe acne vulgaris.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2008
First PostedMar 2008
Primary CompletionSep 2008
TodayJul 2026
First PostedMar 14, 2008
Enrollment StartMar 1, 2008
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 18.3 years ago
Interventions
Doxycycline hyclate (Doryx)drug
150mg/day, oral, delayed release tablets
Doxycycline hyclatedrug
100 mg/day, oral, tablets, immediate release